However, some commonly used chemotherapy drugs for the treatment of advanced or metastatic PEComas include mTOR inhibitors, as dysregulation of the mammalian target of rapamycin (mTOR) pathway is a characteristic feature of PEComas. Here, MTOR is linked to neoplasm with perivascular epithelioid cell differentiation.